Zoetis (ZTS) EBITDA Margin (2012 - 2026)
Zoetis' EBITDA Margin was 38.74% in Q2 2026, down 3.87 percentage points from 42.60% a year earlier but up 2.66 percentage points from the prior quarter.
Powered by 
Analysis
Zoetis (ZTS) EBITDA Margin (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Zoetis' EBITDA Margin was 28.61% through Jun 30, 2026, down 2.03 percentage points year-over-year; for FY2025, it came in at 41.46%, up 0.08 percentage points from FY2024.
- EBITDA Margin shows a five-year change of +1.21 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was 41.38% in FY2024 (+2.05 pp), 39.33% in FY2023 (-0.40 pp), 39.73% in FY2022 (+0.88 pp) and 38.85% in FY2021 (-1.40 pp).
- Quarterly EBITDA Margin has moved between -4.07% (Q4 2021) and 42.63% (Q3 2025) over five years.
- Compared with a year earlier, EBITDA Margin was higher in five of the last eight quarters, with an average year-over-year change of -0.74 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q1 2024 (a gain of 3.57 percentage points); the worst was Q1 2026 (a drop of 4.78 percentage points).
- Per Business Quant data, ZTS's EBITDA Margin in the three quarters before Q2 2026 was 36.07% (Q1 2026), -3.02% (Q4 2025) and 42.63% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 39.16% |
| 10 | Zoetis | 33.38 Bn | 25.23 Bn | 1.80 Bn | 43.44% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.44% |
| Mar 31, 2026 | 42.00% |
| Dec 31, 2025 | 40.26% |
| Sep 30, 2025 | 45.33% |
| Jun 30, 2025 | 45.43% |
| Mar 31, 2025 | 43.81% |
| Dec 31, 2024 | 39.71% |
| Sep 30, 2024 | 44.85% |
| Jun 30, 2024 | 43.46% |
| Mar 31, 2024 | 43.84% |
| Dec 31, 2023 | 39.04% |
| Sep 30, 2023 | 43.89% |
| Jun 30, 2023 | 45.14% |
| Mar 31, 2023 | 43.20% |
| Dec 31, 2022 | 41.27% |
| Sep 30, 2022 | 43.41% |
| Jun 30, 2022 | 42.84% |
| Mar 31, 2022 | 47.43% |
| Dec 31, 2021 | 38.08% |
| Sep 30, 2021 | 43.67% |
API Access
Zoetis EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ZTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ZTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ZTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();